These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


155 related items for PubMed ID: 22315656

  • 1. NF-κB and matrix-dependent regulation of osteopontin promoter activity in allylamine-activated vascular smooth muscle cells.
    Williams ES, Wilson E, Ramos KS.
    Oxid Med Cell Longev; 2012; 2012():496540. PubMed ID: 22315656
    [Abstract] [Full Text] [Related]

  • 2. Collagen suppresses the proliferative phenotype of allylamine-injured vascular smooth muscle cells.
    Wilson E, Parrish AR, Bral CM, Williams ES, Ramos KS.
    Atherosclerosis; 2002 Jun; 162(2):289-97. PubMed ID: 11996948
    [Abstract] [Full Text] [Related]

  • 3. Differential processing of osteopontin characterizes the proliferative vascular smooth muscle cell phenotype induced by allylamine.
    Parrish AR, Ramos KS.
    J Cell Biochem; 1997 May; 65(2):267-75. PubMed ID: 9136084
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Altered protein secretion and extracellular matrix deposition is associated with the proliferative phenotype induced by allylamine in aortic smooth muscle cells.
    Ramos KS, Weber TJ, Liau G.
    Biochem J; 1993 Jan 01; 289 ( Pt 1)(Pt 1):57-63. PubMed ID: 8424772
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. α-Iso-Cubebene Inhibits PDGF-Induced Vascular Smooth Muscle Cell Proliferation by Suppressing Osteopontin Expression.
    Jang MA, Lee SJ, Baek SE, Park SY, Choi YW, Kim CD.
    PLoS One; 2017 Jan 01; 12(1):e0170699. PubMed ID: 28114367
    [Abstract] [Full Text] [Related]

  • 10. Estrogen attenuates integrin-beta(3)-dependent adventitial fibroblast migration after inhibition of osteopontin production in vascular smooth muscle cells.
    Li G, Chen YF, Kelpke SS, Oparil S, Thompson JA.
    Circulation; 2000 Jun 27; 101(25):2949-55. PubMed ID: 10869268
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sphingosine-1-phosphate induces COX-2 expression via PI3K/Akt and p42/p44 MAPK pathways in rat vascular smooth muscle cells.
    Hsieh HL, Wu CB, Sun CC, Liao CH, Lau YT, Yang CM.
    J Cell Physiol; 2006 Jun 27; 207(3):757-66. PubMed ID: 16508949
    [Abstract] [Full Text] [Related]

  • 14. PMC, a potent hydrophilic α-tocopherol derivative, inhibits NF-κB activation via PP2A but not IκBα-dependent signals in vascular smooth muscle cells.
    Hsieh CY, Hsiao G, Hsu MJ, Wang YH, Sheu JR.
    J Cell Mol Med; 2014 Jul 27; 18(7):1278-89. PubMed ID: 24725826
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Novel genomic targets in oxidant-induced vascular injury.
    Partridge CR, Williams ES, Barhoumi R, Tadesse MG, Johnson CD, Lu KP, Meininger GA, Wilson E, Ramos KS.
    J Mol Cell Cardiol; 2005 Jun 27; 38(6):983-96. PubMed ID: 15910882
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Alpha-lipoic acid inhibits matrix metalloproteinase-9 expression by inhibiting NF-kappaB transcriptional activity.
    Kim HS, Kim HJ, Park KG, Kim YN, Kwon TK, Park JY, Lee KU, Kim JG, Lee IK.
    Exp Mol Med; 2007 Feb 28; 39(1):106-13. PubMed ID: 17334234
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.